Quick Takeaways
- INGALLS & SNYDER LLC filed SCHEDULE 13G/A for CORCEPT THERAPEUTICS INC Common Stock (CORT).
- Disclosed ownership: 7.8%.
- Date of event: 31 Dec 2024.
INGALLS & SNYDER LLC - 31 Dec 2024 SCHEDULE 13G/A Report for CORCEPT THERAPEUTICS INC Common Stock (CORT)
- Filing Manager
- INGALLS & SNYDER LLC
- Reporting Manager
- INGALLS & SNYDER LLC
- Symbol
- CORT
- Shares outstanding
- 104,791,295 shares
- Disclosed Ownership
- 8,173,721 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Feb 2025, 17:23:33 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"INGALLS & SNYDER LLC disclosed 7.8% ownership in CORCEPT THERAPEUTICS INC Common Stock (CORT) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Feb 2025, 17:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 7.8% | 8,173,721 | 0 | 0 | THOMAS O BOUCHER JR | MANAGING DIRECTOR |